Nov 11, 2021 4:05pm EST Processa Pharmaceuticals Announces Third Quarter 2021 Results and Provides Corporate Update
Nov 4, 2021 8:15am EDT Processa Pharmaceuticals Announces Next Generation Capecitabine (Combination of PCS6422 and Capecitabine) Inhibits DPD in Phase 1b Interim Analysis